Rapid Micro Biosystems Inc Cl A (RPID)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -41,295 | -27,903 | -13,887 | -60,806 | -44,359 |
| Depreciation Amortization | 2,311 | 1,530 | 759 | 2,837 | 1,977 |
| Accounts receivable | 1,462 | 1,913 | -142 | -364 | 346 |
| Accounts payable and accrued liabilities | -2,157 | -4,064 | -4,141 | 1,484 | -275 |
| Other Working Capital | 479 | -1,419 | -4,555 | -5,325 | -8,155 |
| Other Operating Activity | 3,616 | 4,067 | 5,280 | 3,627 | 3,574 |
| Operating Cash Flow | $-35,584 | $-25,876 | $-16,686 | $-58,547 | $-46,892 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,427 | -974 | -759 | -6,740 | -5,929 |
| Purchase Of Investment | -50,928 | -26,647 | -17,831 | -179,229 | -155,340 |
| Sale Of Investment | 84,500 | 55,000 | 32,500 | 92,500 | 55,000 |
| Investing Cash Flow | $32,145 | $27,379 | $13,910 | $-93,469 | $-106,269 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -27 | -18 | -9 | -33 | -24 |
| Common Stock Issued | 188 | 131 | 131 | 726 | 630 |
| Financing Cash Flow | $161 | $113 | $122 | $693 | $606 |
| Beginning Cash Position | 27,348 | 27,348 | 27,348 | 178,671 | 178,671 |
| End Cash Position | 24,070 | 28,964 | 24,694 | 27,348 | 26,116 |
| Net Cash Flow | $-3,278 | $1,616 | $-2,654 | $-151,323 | $-152,555 |
| Free Cash Flow | |||||
| Operating Cash Flow | -35,584 | -25,876 | -16,686 | -58,547 | -46,892 |
| Capital Expenditure | -1,427 | -974 | -759 | -6,740 | -5,929 |
| Free Cash Flow | -37,011 | -26,850 | -17,445 | -65,287 | -52,821 |